Strategies and practices of outpatient drug management in a university hospital in Guangdong Province during COVID-19
返回论文页
|更新时间:2022-11-03
|
Strategies and practices of outpatient drug management in a university hospital in Guangdong Province during COVID-19
Health Medicine Research and PracticeVol. 19, Issue 7, Pages: 179-181(2022)
作者机构:
广东外语外贸大学门诊部
作者简介:
基金信息:
DOI:
CLC:R95
Published:2022,
扫 描 看 全 文
Liu Zhilin, Li Ling, Chen Xiaorong, et al. Strategies and practices of outpatient drug management in a university hospital in Guangdong Province during COVID-19. [J]. Health Medicine Research and Practice 19(7):179-181(2022)
DOI:
Liu Zhilin, Li Ling, Chen Xiaorong, et al. Strategies and practices of outpatient drug management in a university hospital in Guangdong Province during COVID-19. [J]. Health Medicine Research and Practice 19(7):179-181(2022)DOI:
Strategies and practices of outpatient drug management in a university hospital in Guangdong Province during COVID-19
Objective To investigate the effects of new regulations on outpatient drug costs and drug prescription in a university hospital in Guangdong Province during COVID-19. Methods Patients visited the outpatient department of Guangdong University of Foreign Studies was selected as the subjects. Outpatient drug costs from January to May in 2018
2019 and 2020 were compared with those from June to December in 2018
2019 and 2020. Outpatient prescriptions from January to May in 2018
2019
and 2020 were compared. The satisfaction with outpatient medication management from January to December in 2020 was investigated using our self-made outpatient medication satisfaction survey scale. A total of 10 patients were also interviewed to understand their medication use after the new regulation. Results Compared to the outpatient drug costs from January to May in 2018 and 2019
the costs decreased by 1 663 100 and 1 800 100 RMB during the same period in 2020
respectively. When analyzed by personnel category
faculty and staff outpatient drug costs decreased the most in absolute terms
by 686 000 and 960 400 RMB
respectively. Compared to the outpatient drug costs from June to December in 2018 and 2019
there was a decrease of 245 200 and 88 000 RMB during the same period in 2020
respectively. Compared to the outpatient prescriptions from January to May in 2018 and 2019
there were 17 016 and 20 319 fewer prescriptions during the same period in 2020
respectively. A total of 500 questionnaires were distributed and 493 valid questionnaires were collected
with a valid questionnaire recovery rate of 98.6%. Among the respondents
320 of them were very satisfied
165 were satisfied
with a satisfaction rate of 97%. All 10 patients indicated that the actual amount and costs of medication used did not change markedly after the new regulation. Conclusion The new regulations on outpatient drug prescription management can facilitate the purchase of medication for treatment